SEATTLE, WA, May 3 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Robert Kirkman, M.D., President and Chief Executive Officer,
will present at the 10th Annual JMP Securities Research Conference in San Francisco on Monday,
May 9, 2011, at 11:30 a.m. Pacific Time.
A live and archived webcast of Dr. Kirkman's presentations will be
accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
For further information:
Investor and Media Relations Contact: